Compound information
- Natural Products
- ZC448920
- Molecular Formula
- C15H22N2O4
- Molecular Weight
- 294.157957184 g/mol
- Structure
-
- IUPAC Name
- methyl (2S)-6-amino-2-(benzyloxycarbonylamino)hexanoate
- InChI
- InChI=1S/C15H22N2O4/c1-20-14(18)13(9-5-6-10-16)17-15(19)21-11-12-7-3-2-4-8-12/h2-4,7-8,13H,5-6,9-11,16H2,1H3,(H,17,19)/t13-/m0/s1
- InChI Key
- CZWJWNQZTSMVAZ-ZDUSSCGKSA-N
- SMILES
- COC(=O)[C@H](CCCCN)NC(=O)OCc1ccccc1
- Source
- ZINC000002555065
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 21 | Ring Count | 1 |
Heteroatom Count | 6 | Rotatable Bond Count | 8 |
Hydrogen Bond Acceptor Count | 5 | Hydrogen Bond Donor Count | 2 |
Topological Polar Surface Area | 90.65 Å2 | LogP | 1.578 |
LogS | -1.546 | LogD | 1.049 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.034 | Pgp substrate | 0.782 |
HIA | 0.965 | F20 % | 0.99 |
F30 % | 0.044 | Caco-2 | -4.955 |
MDCK | -5.09 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.648 | PPB | 64.386 |
VD | 1.081 | Fu | 0.271 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.392 | CYP1A2 substrate | 0.768 |
CYP2A6 substrate | 0.457 | CYP2B6 substrate | 0.536 |
CYP2C19 inhibitor | 0.549 | CYP2C19 substrate | 0.859 |
CYP2C8 substrate | 0.743 | CYP2C9 inhibitor | 0.052 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.012 |
CYP2D6 substrate | 0.907 | CYP2E1 substrate | 0.32 |
CYP3A4 inhibitor | 0.053 | CYP3A4 substrate | 0.779 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.861 | CL | 3.067 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.242 | Hepatotoxicity | 0.234 |
Mutagenicity | 0.147 | Rat Oral Acute Toxicity | 0.055 |
FDAMDD | 0.314 | Skin Sensitization | 0.027 |
Carcinogenicity | 0.004 | Eye Corrosion | 0.012 |
Eye Irritation | 0.004 | Respiratory Toxicity | 0.074 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.037 | IGC50 | 2.626 |
LC50FM | 3.474 | LC50DM | 5.42 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.118 | NR-AR-LBD | 0.181 |
NR-AhR | 0.002 | NR-Aromatase | 0.054 |
NR-ER | 0.22 | NR-ER-LBD | 0.401 |
NR-PPAR-gamma | 0.191 | SR-ARE | 0.059 |
SR-ATAD5 | 0.467 | SR-HSE | 0.151 |
SR-MMP | 0.015 | SR-p53 | 0.043 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.